Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nancy Chang
Observed name:
Nancy S. Chang
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Loma Linda University Children's Hospital,
Columbia University
OpenAlex ID:
A5113518811
Impact of electronic medication reconciliation at hospital admission on clinician workflow.
2010
·
David K Vawdrey
, Nancy Chang
, et al.
·
PubMed
·
19
From the FDA
2005
·
Nancy S. Chang
, Arthur F. Simone
, et al.
·
Anesthesiology
·
17
Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
2023
·
Zoe Li
, Jie Liu
, et al.
·
International Journal of Molecular Sciences
·
12
PDF
Acute pain pathways: protocol for a prospective cohort study
2022
·
Molly Moore Jeffery
, Mitra Ahadpour
, et al.
·
BMJ Open
·
8
PDF
The Interface between Substance Abuse and Chronic Pain Management in Primary Care: A Curriculum for Medical Residents
2009
·
Erik W. Gunderson
, Phillip O. Coffin
, et al.
·
Substance Abuse
·
8
Reviewing Case Reports and the Droperidol Warning: FDA Response
2003
·
Nancy Chang
, Arthur Simone
, et al.
·
Anesthesia & Analgesia
·
8
Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
2024
·
Zoe Li
, Ruili Huang
, et al.
·
Molecules
·
3
PDF
448: Methylnaltrexone for Opioid-induced Constipation in Critically Ill Infants and Children
2019
·
Christina Smith
, Joanna Robbins
, et al.
·
Critical Care Medicine
Show more works
View as search
Works count:
8
Citation count:
75
H-index:
6
I10-index:
3
Year
Topic
Type